Clinically relevant determinants of body composition, function and nutritional status as mortality predictors in lung cancer patients

Lung Cancer

Volumn 84, Issue 1, 2014, Pages 1-6

  Kovarik, Miroslav ^a,b   Hronek, Miloslav ^a,b   Zadak, Zdenek ^b  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Anthropometry; Cachexia; Handgrip dynamometry; Lung cancer; Nutritional screening questionnaires; Outcome prediction; Phase angle; Sarcopenia

Indexed keywords

ANTHROPOMETRY; ARM CIRCUMFERENCE; ARM MUSCLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CANCER PATIENT; CLINICAL PRACTICE; DYNAMOMETRY; GRIP STRENGTH; HAND GRIP; HUMAN; LUNG CANCER; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SKINFOLD THICKNESS; SURVIVAL; WRIST;

ANTHROPOMETRY; CACHEXIA; HANDGRIP DYNAMOMETRY; LUNG CANCER; NUTRITIONAL SCREENING QUESTIONNAIRES; OUTCOME PREDICTION; PHASE ANGLE; SARCOPENIA;

ANTHROPOMETRY; BODY COMPOSITION; ELECTRIC IMPEDANCE; HAND STRENGTH; HUMANS; LUNG NEOPLASMS; NUTRITION SURVEYS; NUTRITIONAL STATUS; PROGNOSIS; QUESTIONNAIRES;

EID: 84896711344     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.01.020     Document Type: Review

References (57)

1. Evans W.J., Morley J.E., Argilés J., Bales C., Baracos V., Guttridge D., et al. Cachexia: a new definition. Clin Nutr 2008, 27(6):793-799.
2. Muscaritoli M., Anker S.D., Argilés J., Aversa Z., Bauer J.M., Biolo G., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics. Clin Nutr 2010, 29(2):154-159.
3. Fearon K., Strasser F., Anker S.D., Bosaeus I., Bruera E., Fainsinger R.L., et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011, 12(5):489-495.
4. Gioulbasanis I., Baracos V.E., Giannousi Z., Xyrafas A., Martin L., Georgoulias V., et al. Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history. Ann Oncol 2011, 22(4):835-841.
5. Sánchez-Lara K., Turcott J.G., Juárez E., Guevara P., Núñez-Valencia C., Oñate-Ocaña L.F., et al. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer 2012, 64(4):526-534.
6. Prado C.M., Lieffers J.R., Bowthorpe L., Baracos V.E., Mourtzakis M., McCargar L.J. Sarcopenia and physical function in overweight patients with advanced cancer. Can J Diet Pract Res 2013, 74(2):69-74.
7. van der Meij B.S., Schoonbeek C.P., Smit E.F., Muscaritoli M., van Leeuwen P.A., Langius J.A. Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks. Br J Nutr 2013, 109(12):2231-2239.
8. Brown D.J., McMillan D.C., Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 2005, 103(2):377-382.
9. Mohan A., Singh P., Kumar S., Mohan C., Pathak A.K., Pandey R.M., et al. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer. Asian Pac J Cancer Prev 2008, 9(4):557-562.
10. Prado C.M., Lieffers J.R., McCargar L.J., Reiman T., Sawyer M.B., Martin L., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008, 9(7):629-635.
11. Buccheri G., Ferrigno D. Prognostic factors in lung cancer: tables and comments. Eur Respir J 1994, 7(7):1350-1364.
12. Buccheri G., Ferrigno D. Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer. Lung Cancer 2001, 34(3):433-440.
13. Ferrigno D., Buccheri G. Anthropometric measurements in non-small-cell lung cancer. Support Care Cancer 2001, 9(7):522-527.
14. Jamieson N.B., Brown D.J., Michael Wallace A., McMillan D.C. Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer. Cytokine 2004, 27(2-3):90-92.
15. Tartari R.F., Ulbrich-Kulczynski J.M., Filho A.F. Measurement of mid-arm muscle circumference and prognosis in stage IV non-small cell lung cancer patients. Oncol Lett 2013, 5(3):1063-1067.
16. McDowell M.A., Fryar C.D., Hirsch R., Ogden C.L. Anthropometric reference data for children and adults: U.S. population, 1999-2002. Adv Data 2005, 361:1-5.
17. Leung C.C., Lam T.H., Yew W.W., Chan W.M., Law W.S., Tam C.M. Lower lung cancer mortality in obesity. Int J Epidemiol 2011, 40(1):174-182.
18. Yang R., Cheung M.C., Pedroso F.E., Byrne M.M., Koniaris L.G., Zimmers T.A. Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res 2011, 170(1):e75-e83.
19. Hsu C.L., Chen K.Y., Shih J.Y., Ho C.C., Yang C.H., Yu C.J., et al. Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors. BMC Cancer 2012, 12:241.
20. Luo J., Chen Y.J., Narsavage G.L., Ducatman A. Predictors of survival in patients with non-small cell lung cancer. Oncol Nurs Forum 2012, 39(6):609-616.
21. Martin L., Birdsell L., Macdonald N., Reiman T., Clandinin M.T., McCargar L.J., et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013, 31(12):1539-1547.
22. Jafri S.H., Shi R., Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer 2013, 13:158.
23. Trutschnigg B., Kilgour R.D., Reinglas J., Rosenthall L., Hornby L., Morais J.A., et al. Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Metab 2008, 33(6):1232-1239.
24. Bohannon R.W. Hand-grip dynamometry predicts future outcomes in aging adults. J Geriatr Phys Ther 2008, 31(1):3-10.
25. Piskorz L., Lesiak T., Brocki M., Klimek-Piskorz E., Smigielski J., Misiak P., et al. Biochemical and functional indices of malnutrition in patients with operable, non-microcelullar lung cancer. Nutr Hosp 2011, 26(5):1025-1032.
26. Navigante A., Morgado P.C., Casbarien O., Delgado N.L., Giglio R., Perman M. Relationship between weakness and phase angle in advanced cancer patients with fatigue. Support Care Cancer 2013, 21(6):1685-1690.
27. Mathiowetz V., Kashman N., Volland G., Weber K., Dowe M., Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985, 66(2):69-74.
28. Bohannon R.W., Peolsson A., Massy-Westropp N., Desrosiers J., Bear-Lehman J. Reference values for adult grip strength measured with a Jamar dynamometer: a descriptive meta-analysis. Physiotherapy 2006, 92(1):11-15.
29. Budziareck M.B., Pureza Duarte R.R., Barbosa-Silva M.C. Reference values and determinants for handgrip strength in healthy subjects. Clin Nutr 2008, 27(3):357-362.
30. Kilgour R.D., Vigano A., Trutschnigg B., Lucar E., Borod M., Morais J.A. Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer 2013, 21(12):3261-3270.
31. Fredrix E.W., Saris W.H., Soeters P.B., Wouters E.F., Kester A.D., von Meyenfeldt M.F., et al. Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr 1990, 44(10):749-752.
32. Paiva S.I., Borges L.R., Halpern-Silveira D., Assunção M.C., Barros A.J., Gonzalez M.C. Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer. Support Care Cancer 2010, 19(2):187-192.
33. Norman K., Stobäus N., Pirlich M., Bosy-Westphal A. Bioelectrical phase angle and impedance vector analysis-clinical relevance and applicability of impedance parameters. Clin Nutr 2012, 31(6):854-861.
34. Selberg O., Selberg D. Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 2002, 86(6):509-516.
35. Desport J.C., Marin B., Funalot B., Preux P.M., Couratier P. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008, 9(5):273-278.
36. Abad S., Sotomayor G., Vega A., Pérez de José A., Verdalles U., Jofré R., et al. The phase angle of the electrical impedance is a predictor of long-term survival in dialysis patients. Nefrologia 2011, 31(6):670-676.
37. Araujo Antunes A., Alves Pereira Rodrigues A.P., Geraix J., Vaz de Arruda Silveira L., Câmara Marques Pereira P., Barros Leite Carvalhaes M.A. Nutritional assessment of hospitalized HIV-infected patients by the phase angle z-score measurement. Nutr Hosp 2012, 27(3):771-774.
38. Toso S., Piccoli A., Gusella M., Menon D., Bononi A., Crepaldi G., et al. Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition 2000, 16(2):120-124.
39. Gupta D., Lammersfeld C.A., Vashi P.G., King J., Dahlk S.L., Grutsch J.F., et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer 2009, 9:37.
40. Castanho I.A., Lopes A.J., Koury J.C., Tessarollo B., Silva A.C., Nunes R.A. Relationship between the phase angle and volume of tumours in patients with lung cancer. Ann Nutr Metab 2013, 62(1):68-74.
41. Barbosa-Silva M.C., Barros A.J., Wang J., Heymsfield S.B., Pierson R.N. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr 2005, 82(1):49-52.
42. Bosy-Westphal A., Danielzik S., Dörhöfer R.P., Later W., Wiese S., Müller M.J. Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. JPEN J Parenter Enteral Nutr 2006, 30(4):309-316.
43. Norman K., Stobäus N., Zocher D., Bosy-Westphal A., Szramek A., Scheufele R., et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr 2010, 92(3):612-619.
44. Ottery F.D. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996, 12(1 Suppl.):S15-S19.
45. Guigoz Y., Vellas B., Garry P.J. Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 1996, 54(1 Pt 2):S59-S65.
46. Kondrup J., Allison S.P., Elia M., Vellas B., Plauth M. Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines for nutrition screening 2002. Clin Nutr 2003, 22(4):415-421.
47. Li R., Wu J., Ma M., Pei J., Song Y., Zhang X., et al. Comparison of PG-SGA, SGA and body-composition measurement in detecting malnutrition among newly diagnosed lung cancer patients in stage IIIB/IV and benign conditions. Med Oncol 2011, 28(3):689-696.
48. http://www.mna-elderly.com/ (cited 26. 11. 2013).
49. Rubenstein L.Z., Harker J.O., Salvà A., Guigoz Y., Vellas B. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 2001, 56(6):M366-M372.
50. Isaia G., Mondino S., Germinara C., Cappa G., Aimonino-Ricauda N., Bo M., et al. Malnutrition in an elderly demented population living at home. Arch Gerontol Geriatr 2011, 53(3):249-251.
51. Yatabe M.S., Taguchi F., Ishida I., Sato A., Kameda T., Ueno S., et al. Mini nutritional assessment as a useful method of predicting the development of pressure ulcers in elderly inpatients. J Am Geriatr Soc 2013, 61(10):1698-1704.
52. Liu P., Yan X., Wang B.S., Xu X.D. Three methods assess nutritional status of leukemia patients before hematopoietic stem cell transplantation. Chin Med J (Engl) 2012, 125(3):440-443.
53. Aaldriks A.A., van der Geest L.G., Giltay E.J., le Cessie S., Portielje J.E., Tanis B.C., et al. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol 2013, 4(3):218-226.
54. Gioulbasanis I., Georgoulias P., Vlachostergios P.J., Baracos V., Ghosh S., Giannousi Z., et al. Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis. Lung Cancer 2011, 74(3):516-520.
55. Gioulbasanis I., Patrikidou A., Kitikidou K., Papadimitriou K., Vlachostergios P.J., Tsatsanis C., et al. Baseline plasma levels of interleukin-8 in stage IV non-small-cell lung cancer patients: relationship with nutritional status and prognosis. Nutr Cancer 2012, 64(1):41-47.
56. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67(6):361-370.
57. Giannousi Z., Gioulbasanis I., Pallis A.G., Xyrafas A., Dalliani D., Kalbakis K., et al. Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis. Support Care Cancer 2012, 20(8):1823-1829.